Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Feuerhake

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
A metabolic constraint in the kynurenine pathway drives mucosal inflammation in IBDLina Welz, Danielle Mm Harris, Na-Mi Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- TrialMonika Graeser, Oleg Gluz, Claudia Biehl, et al.
Cancer Cell|June 6, 2014
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapyCarola H Ries, Michael A Cannarile, Sabine Hoves, et al.
The Lancet. Oncology|May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trialSherko Kuemmel, Monika Graeser, Peter Schmid, et al.
Experimental & Molecular Medicine|March 3, 2018
Whither systems medicine?Rolf Apweiler, Tim Beissbarth, Michael R Berthold, et al.
Journal of Crohn'S & Colitis|June 1, 2026
A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBDLina Wehkamp, Danielle M M Harris, Na-Mi Kim, et al.
Blood|December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomasBjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Brain Pathology (Zurich, Switzerland)|December 4, 2018
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomasPia S Zeiner, Corinna Preusse, Anna Golebiewska, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
A metabolic constraint in the kynurenine pathway drives mucosal inflammation in IBDLina Welz, Danielle Mm Harris, Na-Mi Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2022
Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- TrialMonika Graeser, Oleg Gluz, Claudia Biehl, et al.
Cancer Cell|June 6, 2014
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapyCarola H Ries, Michael A Cannarile, Sabine Hoves, et al.
The Lancet. Oncology|May 3, 2025
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trialSherko Kuemmel, Monika Graeser, Peter Schmid, et al.
Experimental & Molecular Medicine|March 3, 2018
Whither systems medicine?Rolf Apweiler, Tim Beissbarth, Michael R Berthold, et al.
Journal of Crohn'S & Colitis|June 1, 2026
A metabolic constraint in de novo NAD+ synthesis drives mucosal inflammation in IBDLina Wehkamp, Danielle M M Harris, Na-Mi Kim, et al.
Blood|December 25, 2015
Targetable genetic features of primary testicular and primary central nervous system lymphomasBjoern Chapuy, Margaretha G M Roemer, Chip Stewart, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 8